{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:27:00Z","timestamp":1784323620987,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,10,11]],"date-time":"2014-10-11T00:00:00Z","timestamp":1412985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00428-014-1666-7","type":"journal-article","created":{"date-parts":[[2014,10,10]],"date-time":"2014-10-10T02:46:07Z","timestamp":1412909167000},"page":"703-713","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Gene expression profiling of giant cell tumor of bone reveals downregulation of extracellular matrix components decorin and lumican associated with lung metastasis"],"prefix":"10.1007","volume":"465","author":[{"given":"M.","family":"Lieveld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"De Boeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Nouman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Cleton-Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Korsching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Benassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Picci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Poffyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. A.","family":"Athanasou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. C. W.","family":"Hogendoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. G.","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,11]]},"reference":[{"issue":"5","key":"1666_CR1","first-page":"1095","volume":"145","author":"MH Zheng","year":"1994","unstructured":"Zheng MH, Fan Y, Wysocki SJ et al (1994) Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration. Am J Pathol 145(5):1095\u20131104","journal-title":"Am J Pathol"},{"issue":"1","key":"1666_CR2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0169-6009(92)90820-4","volume":"16","author":"CJ Joyner","year":"1992","unstructured":"Joyner CJ, Quinn JM, Triffitt JT, Owen ME, Athanasou NA (1992) Phenotypic characterisation of mononuclear and multinucleated cells of giant cell tumour of bone. Bone Miner 16(1):37\u201348","journal-title":"Bone Miner"},{"key":"1666_CR3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0002-9440(10)63323-8","volume":"165","author":"JH Lindeman","year":"2009","unstructured":"Lindeman JH, Hanemaaijer R, Mulder A et al (2009) Cathepsin K is the principal protease in giant cell tumor of bone. Am J Pathol 165:593\u2013600","journal-title":"Am J Pathol"},{"issue":"1","key":"1666_CR4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1359\/jbmr.080905","volume":"24","author":"RG Forsyth","year":"2009","unstructured":"Forsyth RG, De Boeck G, Taminiau AHM et al (2009) CD33+ CD14\u2212 phenotype is characteristic of multinuclear osteoclast-like cells in giant cell tumor of bone. J Bone Miner Res 24(1):70\u201377","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1666_CR5","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1084\/jem.20041785","volume":"201","author":"CET Costa da","year":"2005","unstructured":"da Costa CET, Annels NE, Faaij CMJM, Forsyth RG, Hogendoorn PCW, Egeler RM (2005) Presence of osteoclast-like multinucleated giant cells in the bone and nonostotic lesions of Langerhans cell histiocytosis. J Exp Med 201(5):687\u2013693","journal-title":"J Exp Med"},{"key":"1666_CR6","first-page":"310","volume-title":"WHO classification of tumors of bone: giant cell tumor. In: world health organization classification of tumors. Pathology and genetics of tumors of soft tissue and bone","author":"R Reid","year":"2002","unstructured":"Reid R, Banerjee SS, Sciot R (2002) WHO classification of tumors of bone: giant cell tumor. In: world health organization classification of tumors. Pathology and genetics of tumors of soft tissue and bone. IARC Press, Lyon, pp 310\u2013312"},{"key":"1666_CR7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.humpath.2007.04.022","volume":"39","author":"JR Edwards","year":"2008","unstructured":"Edwards JR, Williams K, Kindblom LG et al (2008) Lymphatics and bone. Hum Pathol 39:49\u201355","journal-title":"Hum Pathol"},{"key":"1666_CR8","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1302\/0301-620X.81B1.9001","volume":"81","author":"HR Blackley","year":"1999","unstructured":"Blackley HR, Wunder JS, Davis AM, White LM, Kandel R, Bell RS (1999) Treatment of giant cell tumors of long bones with curettage and bone grafting. J Bone Joint Surg 81:811\u2013820","journal-title":"J Bone Joint Surg"},{"key":"1666_CR9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ocl.2005.08.005","volume":"37","author":"RE Turcotte","year":"2006","unstructured":"Turcotte RE (2006) Giant cell tumor of bone. Orthop Clin North Am 37:35\u201351","journal-title":"Orthop Clin North Am"},{"key":"1666_CR10","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/1097-0142(19940815)74:4<1253::AID-CNCR2820740412>3.0.CO;2-9","volume":"74","author":"RC Marcove","year":"1994","unstructured":"Marcove RC, Sheth DS, Brien EW, Huvos AG, Healey JH (1994) Conservative surgery for giant cell tumors of sacrum. The role of cryosurgery as a supplement to curettage and partial excision. Cancer 74:1253\u20131260","journal-title":"Cancer"},{"key":"1666_CR11","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1245\/s10434-009-0803-z","volume":"17","author":"SV Domovitov","year":"2010","unstructured":"Domovitov SV, Healey JH (2010) Primary malignant giant-cell tumor of bone has high survival rate. Ann Surg Oncol 17:694\u2013701","journal-title":"Ann Surg Oncol"},{"key":"1666_CR12","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00432-008-0370-x","volume":"134","author":"M Balke","year":"2008","unstructured":"Balke M, Schremper L, Gebert C et al (2008) Giant cell tumor of bone: Treatment and outcome of 214 cases. J Cancer Res Clin Oncol 134:969\u2013978","journal-title":"J Cancer Res Clin Oncol"},{"key":"1666_CR13","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/cncr.11359","volume":"97","author":"F Bertoni","year":"2003","unstructured":"Bertoni F, Bacchini P, Staals E (2003) Malignancy in giant cell tumor of bone. Cancer 97:2520\u20132529","journal-title":"Cancer"},{"key":"1666_CR14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/modpathol.3801023","volume":"21","author":"C Lee","year":"2008","unstructured":"Lee C, Espinosa I, Jensen KC et al (2008) Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of bone. Mod Pathol 21:531\u2013539","journal-title":"Mod Pathol"},{"key":"1666_CR15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/modpathol.2009.134","volume":"23","author":"L Moskovszky","year":"2010","unstructured":"Moskovszky L, Dezs\u00f6 K, Athanasou NA et al (2010) Centrosome abnormalities in giant cell tumor of bone: Possible association with chromosomal instability. Mod Pathol 23:359\u2013366","journal-title":"Mod Pathol"},{"key":"1666_CR16","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1089\/cmb.2006.13.1513","volume":"13","author":"B Moerkerke","year":"2006","unstructured":"Moerkerke B, Goetghebeur E (2006) Selecting \u201csignificant\u201d differentially expressed genes from the combined perspective of the null and the alternative. J Comput Biol 13:1513\u20131531","journal-title":"J Comput Biol"},{"key":"1666_CR17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0002-9440(10)62959-8","volume":"167","author":"T Morgan","year":"2005","unstructured":"Morgan T, Atkins GJ, Trivett MK et al (2005) Molecular profiling of giant cell tumor of bone and the osteclastic localization of ligand for receptor activator of nuclear factor \u03ba B. Am J Pathol 167:117\u2013128","journal-title":"Am J Pathol"},{"key":"1666_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0945-053X(98)90121-4","volume":"17","author":"AM Hocking","year":"1998","unstructured":"Hocking AM, Shinomura T, McQuillan DJ (1998) Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol 17:1\u201319","journal-title":"Matrix Biol"},{"key":"1666_CR19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jcp.10142","volume":"192","author":"SM Pupa","year":"2002","unstructured":"Pupa SM, M\u00e9nard S, Forti S, Tagliabe E (2002) New insights into the role of extracellular matrix during tumor onset and progression. J Cell Physiol 192:259\u2013267","journal-title":"J Cell Physiol"},{"key":"1666_CR20","doi-asserted-by":"crossref","first-page":"21305","DOI":"10.1074\/jbc.R800020200","volume":"31","author":"L Schaefer","year":"2008","unstructured":"Schaefer L, Iozzo RV (2008) Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem 31:21305\u201321309","journal-title":"J Biol Chem"},{"key":"1666_CR21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1083\/jcb.136.3.729","volume":"136","author":"KG Danielson","year":"1997","unstructured":"Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV (1997) Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 136:729\u2013743","journal-title":"J Cell Biol"},{"key":"1666_CR22","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1083\/jcb.141.5.1277","volume":"141","author":"S Chakravarti","year":"1998","unstructured":"Chakravarti S, Magnuson T, Lass JH, Jepsen KJ, LaMantia C, Carroll H (1998) Lumican regulates collagen fibril assembly: Skin fragility and corneal opacity in the absence of lumican. J Cell Biol 141:1277\u20131286","journal-title":"J Cell Biol"},{"issue":"2","key":"1666_CR23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ajpath.2012.04.029","volume":"181","author":"T Neill","year":"2012","unstructured":"Neill T, Schaefer L, Iozzo RV (2012) Decorin: a guardian from the matrix. Am J Pathol 181(2):380\u2013387","journal-title":"Am J Pathol"},{"key":"1666_CR24","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1042\/bj3150815","volume":"315","author":"S Kaname","year":"1996","unstructured":"Kaname S, Ruoslahti E (1996) Betaglycan has multiple binding sites for transforming growth factor-beta 1. Biochem J 315:815\u2013820","journal-title":"Biochem J"},{"key":"1666_CR25","doi-asserted-by":"crossref","first-page":"18842","DOI":"10.1074\/jbc.M700243200","volume":"282","author":"C Cabello-Verrugio","year":"2007","unstructured":"Cabello-Verrugio C, Brandan E (2007) A novel modulatory mechanism of transforming growth factor-\u03b2 signaling through decorin and LRP-1. J Biol Chem 282:18842\u201318850","journal-title":"J Biol Chem"},{"key":"1666_CR26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1083\/jcb.200901129","volume":"185","author":"S Goldoni","year":"2009","unstructured":"Goldoni S, Humphries A, Nystr\u00f6m A et al (2009) Decorin is a novel antagonistic ligand of the Met receptor. J Cell Biol 185:743\u2013754","journal-title":"J Cell Biol"},{"key":"1666_CR27","doi-asserted-by":"crossref","first-page":"32468","DOI":"10.1074\/jbc.M503833200","volume":"280","author":"JX Zhu","year":"2005","unstructured":"Zhu JX, Goldoni S, Bix G et al (2005) Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis. J Biol Chem 280:32468\u201332479","journal-title":"J Biol Chem"},{"issue":"12","key":"1666_CR28","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/iub.131","volume":"60","author":"D Nikitovic","year":"2008","unstructured":"Nikitovic D, Katonis P, Tsatsakis A, Karamanos NK, Tzanakakis GN (2008) Lumican, a small leucine-rich proteoglycan. IUBMB Life 60(12):818\u2013823","journal-title":"IUBMB Life"},{"key":"1666_CR29","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.yexcr.2004.02.005","volume":"296","author":"B Vuillermoz","year":"2004","unstructured":"Vuillermoz B, Khoruzhenko A, D\u2019Onofrio MF et al (2004) The small leucine-rich proteoglycan lumican inhibits melanoma progression. Exp Cell Res 296:294\u2013306","journal-title":"Exp Cell Res"},{"key":"1666_CR30","first-page":"207","volume":"9","author":"S Troup","year":"2003","unstructured":"Troup S, Njue C, Kliewer EV et al (2003) Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res 9:207\u2013214","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1666_CR31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1742-4658.2007.06205.x","volume":"275","author":"D Nikitovic","year":"2008","unstructured":"Nikitovic D, Berdiaki A, Zafiropoulos A et al (2008) Lumican expression is positively correlated with the differentiation and negatively with the growth of human osteosarcoma cells. FEBS J 275(2):350\u2013361","journal-title":"FEBS J"},{"issue":"3","key":"1666_CR32","first-page":"337","volume":"24","author":"HJ Knowles","year":"2009","unstructured":"Knowles HJ, Athanasou NA (2009) Canonical and non-canonical pathways of osteoclast formation. Histol Histopathol 24(3):337\u2013346","journal-title":"Histol Histopathol"},{"issue":"3","key":"1666_CR33","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0002-9440(10)64950-4","volume":"156","author":"V Wallenius","year":"2000","unstructured":"Wallenius V, Hisaoka M, Helou K et al (2000) Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive\/malignant human musculoskeletal tumors. Am J Pathol 156(3):821\u2013829","journal-title":"Am J Pathol"},{"issue":"10","key":"1666_CR34","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/labinvest.2012.108","volume":"92","author":"RM Taylor","year":"2012","unstructured":"Taylor RM, Kashima TG, Knowles HJ, Athanasou NA (2012) VEGF, FLT3 ligand, PlGF and HGF can substitute for M-CSF to induce human osteoclast formation: implications for giant cell tumour pathobiology. Lab Invest 92(10):1398\u20131406","journal-title":"Lab Invest"},{"issue":"1","key":"1666_CR35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bone.2003.08.008","volume":"34","author":"I Itonaga","year":"2004","unstructured":"Itonaga I, Sabokbar A, Sun SG, Kudo O, Danks L, Ferguson D, Fujikawa Y, Athanasou NA (2004) Transforming growth factor-beta induces osteoclast formation in the absence of RANKL. Bone 34(1):57\u201364","journal-title":"Bone"},{"issue":"11","key":"1666_CR36","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0024-3205(03)00434-X","volume":"73","author":"SM Kumta","year":"2003","unstructured":"Kumta SM, Huang L, Cheng YY, Chow LT, Lee KM, Zheng MH (2003) Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions. Life Sci 73(11):1427\u20131436","journal-title":"Life Sci"},{"issue":"1","key":"1666_CR37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/path.2319","volume":"215","author":"HJ Knowles","year":"2008","unstructured":"Knowles HJ, Athanasou NA (2008) Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF. J Pathol 215(1):56\u201366","journal-title":"J Pathol"},{"issue":"8","key":"1666_CR38","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1074\/jbc.M111.283499","volume":"287","author":"E Neill","year":"2012","unstructured":"Neill E (2012) T, Painter H, Buraschi S et al. Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1\u03b1, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3. J Biol Chem 287(8):5492\u20135506","journal-title":"J Biol Chem"},{"key":"1666_CR39","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/gcc.20035","volume":"40","author":"WH Catherino","year":"2004","unstructured":"Catherino WH, Leppert PC, Stenmark MH et al (2004) Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes Chromosomes Cancer 40:204\u2013217","journal-title":"Genes Chromosomes Cancer"},{"key":"1666_CR40","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/0264-6021:3370537","volume":"337","author":"O Okamoto","year":"1999","unstructured":"Okamoto O, Fujiwara S, Abe M, Sato Y (1999) Dermatopontin interacts with transforming growth factor \u03b2 and enhances its biological activity. Biochem J 337:537\u2013541","journal-title":"Biochem J"},{"issue":"4","key":"1666_CR41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/03008200600846564","volume":"47","author":"O Okamoto","year":"2006","unstructured":"Okamoto O, Fujiwara S (2006) Dermatopontin, a novel player in the biology of the extracellular matrix. Connect Tissue Res 47(4):177\u2013189","journal-title":"Connect Tissue Res"},{"key":"1666_CR42","doi-asserted-by":"crossref","first-page":"e1000869","DOI":"10.1371\/journal.pgen.1000869","volume":"6","author":"AC Groner","year":"2010","unstructured":"Groner AC, Meylan S, Ciuffi A et al (2010) KRAB-zinc finger proteins and KAP1 can mediate long-range transcriptional repression through heterochromatin spreading. PLoS Genet 6:e1000869","journal-title":"PLoS Genet"},{"key":"1666_CR43","unstructured":"Robin NH, Moran RT, Warman M, Ala-Kokko L. Stickler Syndrome. GeneReviews. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1302\/ . Accessed Nov 3 2011"},{"key":"1666_CR44","doi-asserted-by":"crossref","first-page":"18709","DOI":"10.1074\/jbc.272.30.18709","volume":"272","author":"HJ Johnson","year":"1997","unstructured":"Johnson HJ, Rosenberg L, Choi HU, Garza S, H\u00f6\u00f6k M, Neame PJ (1997) Characterization of epiphycan, a small proteoglycan with a leucine-rich repeat core protein. J Biol Chem 272:18709\u201318717","journal-title":"J Biol Chem"},{"key":"1666_CR45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/scdb.2000.0243","volume":"12","author":"CB Knudson","year":"2001","unstructured":"Knudson CB, Knudson W (2001) Cartilage proteoglycans. Semin Cell Dev Biol 12:69\u201378","journal-title":"Semin Cell Dev Biol"},{"issue":"9","key":"1666_CR46","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1359\/JBMR.040412","volume":"19","author":"YS Chung","year":"2004","unstructured":"Chung YS, Baylink DJ, Srivastava AK et al (2004) Effects of secreted frizzled-related protein 3 on osteoblasts in vitro. J Bone Miner Res 19(9):1395\u20131402","journal-title":"J Bone Miner Res"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-014-1666-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-014-1666-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-014-1666-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:36:16Z","timestamp":1559064976000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-014-1666-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,11]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1666"],"URL":"https:\/\/doi.org\/10.1007\/s00428-014-1666-7","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,11]]}}}